| Sep'13 | Jun'13 | Mar'13 | Dec'12 | Sep'12 | Jun'12 | Mar'12 | Dec'11 | Sep'11 | Jun'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash | ||||||||||
1 | - | 0 | 159 | 72 | 4 | 101 | 5 | 0 | 0 | 1 |
Accounts receivable, net | ||||||||||
0 | 38 | 189 | 211 | 209 | 290 | 195 | 128 | 150 | 98 | 48 |
Inventory | ||||||||||
- | 75 | 76 | 139 | 244 | 122 | 19 | 0 | - | 44 | 0 |
Prepaid expenses and other current assets | ||||||||||
9 | 70 | 128 | 98 | 61 | 40 | 32 | 23 | 20 | 19 | 12 |
Total current assets | ||||||||||
11 | 184 | 393 | 608 | 587 | 458 | 348 | 158 | 171 | 162 | 62 |
Total Assets | ||||||||||
11 | 184 | 393 | 608 | 587 | 458 | 348 | 158 | 171 | 162 | 62 |
Liabilities and Stockholders' Deficiency | ||||||||||
Current liabilities: | ||||||||||
Accounts payable | ||||||||||
1,537 | 1,485 | 1,361 | 993 | 1,080 | 1,240 | 1,196 | 1,179 | 1,203 | 1,195 | 1,588 |
Due to factor | ||||||||||
118 | 146 | 254 | 213 | 148 | 167 | 50 | 82 | 108 | 70 | 0 |
Accrued expenses and other current liabilities | ||||||||||
1,828 | 1,851 | 1,670 | 1,734 | 1,549 | 2,595 | 2,136 | 2,001 | 1,854 | 1,714 | 1,053 |
Derivative liabilities | ||||||||||
1,393 | 171 | 219 | 432 | 3,948 | 2,978 | 789 | 155 | 229 | 299 | 84 |
Notes payable to related parties and others, net of discounts | ||||||||||
4,972 | 4,748 | 4,424 | 3,936 | 2,964 | 1,896 | 1,398 | 1,128 | 845 | 781 | 465 |
Total current liabilities | ||||||||||
9,850 | 8,404 | 7,929 | 7,310 | 9,691 | 8,878 | 5,571 | 4,547 | 4,241 | 4,061 | 3,191 |
Stockholders' Deficiency: | ||||||||||
Preferred stock, no stated value; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2013 and December 31, 2012 | ||||||||||
0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common stock, $.0001 par value, 100,000,000 shares authorized, 18,473,554 and 17,795,376 shares issued and outstanding as of September 30, 2013 and December 31, 2012,respectively. In addition,36,300,000 and 0 shares issued in reserve and outstanding at September 30, 2013 and December 31, 2012, respectively. | ||||||||||
1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Additional paid-in capital | ||||||||||
14,287 | 14,256 | 14,152 | 13,872 | 12,229 | 9,299 | 9,161 | 9,064 | 8,984 | 8,535 | 7,267 |
Accumulated deficit | ||||||||||
-22,478 | -22,478 | -21,690 | - | -21,333 | -17,719 | -14,385 | -13,454 | -13,055 | -12,434 | -10,396 |
Deficit accumulated during the development stage | ||||||||||
1,650 | - | - | 20,576 | - | - | - | - | - | - | - |
Total stockholders' deficiency | ||||||||||
-9,838 | -8,219 | -7,535 | -6,702 | -9,103 | -8,419 | -5,222 | -4,389 | -4,069 | -3,898 | -3,128 |
Total Liabilities and Stockholders' Deficiency | ||||||||||
11 | 184 | 393 | 608 | 587 | 458 | 348 | 158 | 171 | 162 | 62 |